SCHEMBL2350412

SCHEMBL2350412

c1ccc2c(-n3c(N4CCNCC4)cc4ccccc43)cccc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 6/20 0.63
▸ HTR5A P47898 3/20 0.63
▸ NCF1 P14598 3/20 0.63
▸ HTR2A P28223 2/20 0.63
▸ HTR3E A5X5Y0 2/20 0.63
▸ HTR3B O95264 2/20 0.63
▸ HTR3A P46098 2/20 0.63
▸ HTR3D Q70Z44 2/20 0.63
▸ HTR3C Q8WXA8 2/20 0.63
▸ SIGMAR1 Q99720 2/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ HTR1A P08908 1/20 0.63
▸ CYP2D6 P10635 1/20 0.63
▸ TSHR P16473 1/20 0.63
▸ NFKB1 P19838 1/20 0.63
▸ HTR1D P28221 1/20 0.63
▸ HTR1B P28222 1/20 0.63
▸ HTR7 P34969 1/20 0.63
▸ MTOR P42345 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555106 0.80 HTR3E (0.53) HTR6HTR5ANCF1HTR2AHTR3E
SCHEMBL3166780 0.78 HTR6 (1.00) HTR6HTR5ANCF1HTR2AHTR3E
SCHEMBL240244 0.78 HTR6 (1.00) HTR6HTR5ANCF1HTR2AHTR3E
SCHEMBL29385724 0.78 HTR6 (1.00) HTR6HTR5ANCF1HTR2AHTR3E
Hydrochloric Acid SCHEMBL25379293 0.77 LMNA (1.00) HTR6HTR5ANCF1HTR2AHTR3E
Hydrochloric Acid SCHEMBL466870 0.77 LMNA (1.00) HTR6HTR5ANCF1HTR2AHTR3E
Hydrochloric Acid SCHEMBL27664894 0.77 LMNA (1.00) HTR6HTR5ANCF1HTR2AHTR3E
SCHEMBL2345155 0.76 HTR1A (0.44) HTR6HTR5ANCF1HTR2AHTR3E
SCHEMBL2346242 0.76 ADRB1 (0.60) HTR6HTR5AHTR2AHTR3EHTR3B
SCHEMBL2345082 0.75 HTR3E (0.48) HTR6HTR5ANCF1HTR2AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback